美国BioCryst Pharmaceuticals
　BioCryst公司是一家在治疗传染性疾病、癌症及炎症的小分子药物研发领域处于世界领先地位的医药公司。Peramivir是BioCryst公司研发的可有效阻止流感病毒神经氨酸酶交互作用的抗病毒体，而流感病毒神经氨酸酶是促使流感病毒在寄主体内传播的一种关键酶。在实验中，peramivir对H1N1甲流原病毒株显示出活性，同时对并发及非并发症流感有显著效果。

Founded in 1986, BioCryst has over 80 employees spread across our two locations in Birmingham, Alabama and Durham, North Carolina. With expertise in drug discovery, clinical development and regulatory affairs, we continue to advance our compounds, peramivir, forodesine and BCX4208, and to generate new compounds from our own discovery engine—structure-based drug design.

We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives.

The commitment of BioCryst has remained unchanged. We continue to be passionate about advancing novel therapeutics for patients with serious diseases.